The World Health Organization on Monday released new guidance on GLP-1 medications for adults with obesity, recommending ...

The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally ...

The five-year SURMOUNT-REAL UK trial, part of a collaboration signed last year between Lilly and the UK government, will ...

A large cohort study found three popular GLP-1-based diabetes drugs -- semaglutide, dulaglutide, and tirzepatide -- carry similar risks for serious adverse GI events, with a rate of about 12 per 1,000 ...

Tirzepatide produced significant weight loss, reduced insulin requirements, and improved glucose control without increasing hypoglycemia when used off-label in adults with type 1 diabetes (T1D), new ...

Millions of Americans are now taking GLP-1 medications, and the drugs are affecting their lives in about as many ways — far beyond the numbers on the scale. (Photo illustration: Yahoo News; photos: ...

Obesity is linked to many diseases, including cancer. A recent study found that tumors in mice shrank after they were administered tirzepatide. It could take years for GLP-1 drugs to obtain regulatory ...

The debate over whether GLP-1 medications raise the risk of eye conditions that could lead to vision loss continues. Scientists have been closely studying this association as more people turn to these ...

Share on Pinterest Serena Williams recently shared her weight loss journey with the GLP-1 medication Zepbound. Joe Buglewicz/Getty Images for International Tennis Hall of Fame Serena Williams recently ...

Eli Lilly and Company is rated Sell due to extreme dependence on GLP-1 drugs & valuation that assumes near-perfect conditions ...

Delaware-Based Telehealth Platform Reports Increased Patient Interest in Cash-Pay Compounded Semaglutide and Tirzepatide Programs as Thanksgiving Week Signals Start of Annual Weight Loss Planning ...